US Codex
U.S.C.
Notes

§1395i–3. Requirements for, and assuring quality of care in, skilled nursing facilities — Inbound Citations

42 U.S.C. § 1395i–3

Cited by 37 provisions in release 119-102.

Citations to 42 U.S.C. § 1395i–3 as a whole

Citations to §1395i–3(a)

Citations to §1395i–3(a)(1)

  • (2) ending with the close of the first period of 60 consecutive days thereafter on each of which he is neither an inpatient of a hospital or critical access hospital nor an inpatient of a facility described in section 1395i–3(a)(1) of this title or subsection (y)(1).
  • (n) The term “durable medical equipment” includes iron lungs, oxygen tents, hospital beds, and wheelchairs (which may include a power-operated vehicle that may be appropriately used as a wheelchair, but only where the use of such a vehicle is determined to be necessary on the basis of the individual’s medical and physical condition and the vehicle meets such safety requirements as the Secretary may prescribe) used in the patient’s home (including an institution used as his home other than an institution that meets the requirements of subsection (e)(1) of this section or section 1395i–3(a)(1) of this title), whether furnished on a rental basis or purchased, and includes blood-testing strips and blood glucose monitors for individuals with diabetes without regard to whether the individual has Type I or Type II diabetes or to the individual’s use of insulin (as determined under standards established by the Secretary in consultation with the appropriate organizations) and eye tracking and gaze interaction accessories for speech generating devices furnished to individuals with a demonstrated medical need for such accessories; except that such term does not include such equipment furnished by a supplier who has used, for the demonstration and use of specific equipment, an individual who has not met such minimum training standards as the Secretary may establish with respect to the demonstration and use of such specific equipment. With respect to a seat-lift chair, such term includes only the seat-lift mechanism and does not include the chair. Beginning with the first calendar quarter beginning on or after the date that is 1 year after February 3, 2026, an external infusion pump and associated home infusion drug (as defined in subsection (iii)(3)(C)) or other associated supplies that do not meet the appropriate for use in the home requirement applied to the definition of durable medical equipment under section 414.202 of title 42, Code of Federal Regulations (or any successor to such regulation) shall be treated as meeting such requirement if each of the following criteria is satisfied:
    (1) The prescribing information approved by the Food and Drug Administration for the home infusion drug associated with the pump instructs that the drug should be administered by or under the supervision of a health care professional.
    (2) A qualified home infusion therapy supplier (as defined in subsection (iii)(3)(D)) administers or supervises the administration of the drug or biological in a safe and effective manner in the patient’s home (as defined in subsection (iii)(3)(B)).
    (3) The prescribing information described in paragraph (1) instructs that the drug should be infused at least 12 times per year—
    (A) intravenously or subcutaneously; or
    (B) at infusion rates that the Secretary determines would require the use of an external infusion pump.
  • (B) ending with the close of the first period of 60 consecutive days thereafter on each of which the individual is neither an inpatient of a hospital or critical access hospital nor an inpatient of a facility described in section 1395i–3(a)(1) of this title or subsection (y)(1) nor provided home health services.

Citations to §1395i–3(b)(1)(B)

Citations to §1395i–3(b)(3)

Citations to §1395i–3(e)

Citations to §1395i–3(e)(5)

Citations to §1395i–3(f)(2)(A)(i)

Citations to §1395i–3(g)

Citations to §1395i–3(g)(1)(C)

Citations to §1395i–3(h)(2)(B)

Citations to §1395i–3(h)(2)(C)

Citations to §1395i–3(i)